GUT-TARGETED NLRP3 ANTAGONISTS AND THEIR USE IN THERAPY Application WO-2021002887-A1 World Intellectual Property Organisation (WIPO) 07 Jan 2021
METHODS OF TREATING OR SELECTING A TREATMENT FOR A SUBJECT RESISTANT TO TNF INHIBITOR… Application WO-2020010118-A1 World Intellectual Property Organisation (WIPO) 09 Jan 2020